Class 3.2 ibuprofen deoxyepinephrine tablet of Kangzhi Pharmaceutical Co., Ltd. has been applied for clinical acceptance

Ibuprofen deoxyepinephrine tablet is a kind of over-the-counter cold medicine It is a compound cold preparation composed of antipyretic analgesic (ibuprofen) and decongestant (adrenaline oxychloride) It is used to relieve the headache, fever, nose congestion and other related symptoms of common cold or influenza It is a compound preparation which has been sold abroad but not yet in China The approval of the drug application shall be subject to the approval of the State Food and drug administration After the approval, clinical trials will be conducted according to the requirements of the approval results After the clinical trials are successful, production approval documents will be applied according to the procedures Whether the application can be reviewed and approved by the State Food and drug administration is uncertain It is not expected that the event will have an impact on the company's performance in 2014 Appendix: announcement of Hainan Kangzhi Pharmaceutical Co., Ltd on the acceptance of ibuprofen deoxyepinephrine tablets registration application the company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions Hainan Kangzhi Pharmaceutical Co., Ltd (hereinafter referred to as "the company") recently received the notice of acceptance of drug registration application from the State Food and Drug Administration for the clinical application of ibuprofen deoxyepinephrine tablets, a chemical drug of category 3.2 Ibuprofen deoxyepinephrine tablet is a kind of over-the-counter cold medicine It is a compound cold preparation composed of antipyretic analgesic (ibuprofen) and decongestant (adrenaline oxychloride) It is used to relieve the headache, fever, nose congestion and other related symptoms of common cold or influenza It is a compound preparation that has been sold abroad but not yet in China Whether ibuprofen deoxyepinephrine tablets are approved or not must be approved by the State Food and drug administration After the approval, clinical trials will be conducted according to the requirements of the approval results After the clinical trials are successful, production approval documents will be applied according to the procedures Whether the application can be reviewed and approved by the State Food and drug administration is uncertain It is expected that this event will not affect the company's performance in 2014 We sincerely invite investors to make prudent decisions and guard against investment risks It is hereby announced Board of directors of Hainan Kangzhi Pharmaceutical Co., Ltd November 21, 2014